MOSAIC (MOthers' AdvocateS In the Community) for Pregnant Women and Mothers of Children Under 5 With Experience of Intimate Partner Violence
MOSAIC Plus
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this R34 exploratory research proposal is to conduct formative work for a larger randomized controlled trial (RCT) evaluating the effectiveness of the "Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms. The proposed study will enroll pregnant women who report experience of IPV in the past 6 months, and who screen positive for elevated depressive and/or PTSD symptoms. The intervention lasts 6 months after enrollment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2021
CompletedFirst Posted
Study publicly available on registry
November 3, 2021
CompletedStudy Start
First participant enrolled
October 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 27, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 27, 2026
CompletedMay 22, 2026
May 1, 2026
1.4 years
October 22, 2021
May 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
acceptability
We will evaluate the acceptability of the proposed recruitment methods, research design, intervention training methods, and of delivering the MOSAIC Plus and MOSAIC interventions by using End of Treatment Questionnaire.
9 months
Satisfaction with care
We will evaluate the feasibility of the proposed recruitment methods, research design, intervention training methods, and of delivering the MOSAIC Plus and MOSAIC interventions by using Client Satisfaction Questionnaire.
9 months
Quality of Working Relationship
We will evaluate therapeutic alliance by using Working Alliance Inventory-Short Revised (WAI-SR)
9 months
Reduction in depressive symptoms
We will measure reduction in depressive symptoms as assessed by Patient Health Questionnaire (PHQ-9).
baseline, 3, 6 and 9 months
Reduction in Posttraumatic Stress Disorder Symptoms
We will measure reduction in posttraumatic stress disorder symptoms by using Davidson Trauma Scale.
baseline, 3, 6 and 9 months
Secondary Outcomes (6)
Intimate Partner Violence
baseline, 3, 6 and 9 months
Effectiveness Obtaining Resources
baseline, 3, 6 and 9 months
Perceived Social Support
baseline, 3, 6 and 9 months
Functioning
baseline, 3, 6 and 9 months
Self-care and self-worth
baseline, 3, 6 and 9 months
- +1 more secondary outcomes
Other Outcomes (2)
Provider Competencies
6 and 9 months
Quality of working relationship-provider perspective
3, 6 and 9 months
Study Arms (2)
MOSAIC Plus
EXPERIMENTAL"Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate IPT principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.
MOSAIC
ACTIVE COMPARATORThose in the active comparator will receive the "Mother AdvocateS In the Community (MOSAIC) Plus" intervention to reduce depressive and PTSD symptoms and prevent additional IPV among pregnant women and mothers with children under 5 experiencing IPV.
Interventions
Those in the experimental arm will receive the intervention is called "Mother AdvocateS In the Community (MOSAIC) Plus", an intervention to reduce depressive and PTSD symptoms and prevent additional intimate partner violence among pregnant women and mothers with children under 5 experiencing IPV. The MOSAIC Plus intervention will integrate interpersonal psychotherapy principles and skills into the MOSAIC intervention in order to expand it to address consequences of IPV, including depression and PTSD symptoms.
Those in the active comparator will receive a mentor mother intervention named Mother AdvocateS In the Community (MOSAIC). This does not include the IPT component.
Eligibility Criteria
You may qualify if:
- Pregnant and/or are mothers of children under 5 and r
- Report IPV experiences in the past 6 months (as assessed by Composite Abuse Scale)
- Aged 18 or above,
- Have elevated depressive and/or PTSD symptoms as assessed by Patient Health Questionnaire (PHQ-9) with a cutoff point of ≥9, and/or the Davidson Trauma Scale (DTS) with a cut-off point of ≥40.
You may not qualify if:
- Cannot provide the name and contact information of at least two locator persons,
- Do not have access to any telephone,
- Cannot understand English well enough to understand the consent form or assessment instruments when they are read aloud
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
YWCA Flint
Flint, Michigan, 48502, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 22, 2021
First Posted
November 3, 2021
Study Start
October 8, 2024
Primary Completion
February 27, 2026
Study Completion
February 27, 2026
Last Updated
May 22, 2026
Record last verified: 2026-05